Immix Biopharma Eulerpool Ziņas

Immix Biopharma Eulerpool News

Immix Biopharma Akciju Ziņas

Immix Biopharma tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās Immix Biopharma ziņas mēs apkopojam šeit.

• 29. augusts ·

  Yahoo
  Immix Biopharma Independent Director Acquires 2.6% More Stock
• 28. augusts ·

  Yahoo
  Immix Biopharma Expands U.S. Clinical Sites for relapsed/refractory AL Amyloidosis Trial NEXICART-2
• 28. augusts ·

  Thefly.com
  Immix Biopharma announces three more sites for NEXICART-2 trial
• 19. augusts ·

  Yahoo
  What Makes Immix Biopharma (IMMX) a New Buy Stock
• 19. augusts ·

  TipRanks
  Analysts Offer Insights on Healthcare Companies: Equillium (EQ), Foghorn Therapeutics (FHTX) and Immix Biopharma, Inc. (IMMX)
• 12. augusts ·

  InvestorPlace
  IMMX Stock Earnings: Immix Biopharma Beats EPS for Q2 2024
• 26. jūlijs ·

  TipRanks
  Buy Rating Affirmed: NXC-201’s Promising Clinical Trials and Strategic CIRM Grant Propel Positive Outlook
• 26. jūlijs ·

  Thefly.com
  Immix Biopharma awarded $8M CLIN2 grant
• 26. jūlijs ·

  Yahoo
  California Institute for Regenerative Medicine Awards Funding for CAR-T NXC-201 U.S. AL Amyloidosis Clinical Trial (NEXICART-2)
• 8. jūlijs ·

  Yahoo
  Immix Biopharma Doses 1st Patient in U.S. AL Amyloidosis Trial with CAR-T NXC-201